Sunday, December 22, 2024
- Advertisement -spot_img

TAG

SPG50

AAV Therapy: A Successful One-Patient SPG50 Gene Therapy Trial

In hereditary spastic paraplegia type 50 (SPG50)—an ultrarare form of neurodevelopmental/neurological disorder described as ideal for gene therapy—Canadian researchers successfully created and completed a...

Latest news

- Advertisement -spot_img